Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call

Core Points - Molecular Partners AG is a clinical-stage biotech company focused on developing DARPin therapeutics, which are custom-built protein drugs aimed at addressing medical challenges that other drug modalities cannot effectively tackle [6] - The company will present at several upcoming investor conferences, including the TD Cowen 44th Annual Health Care Conference and the Leerink Partners Global Healthcare Conference [3][5] - A conference call to discuss the full-year 2024 financial results is scheduled for March 7, 2025, with the Annual Report to be published on March 6, 2025 [2][4] Event Details - At the TD Cowen 44th Annual Health Care Conference in Boston, MA, CEO Patrick Amstutz and CMO Dr. Philippe Legenne will participate in a fireside chat on March 3, 2025, at 9:10 am ET [3] - The full-year 2024 financial results conference call will take place on March 7, 2025, at 8:00 am ET, with registration details provided for participants [4][8] - At the Leerink Partners Global Healthcare Conference in Miami, FL, the same executives will engage in a fireside chat on March 10, 2025, at 10:40 am ET [5] Company Overview - Molecular Partners AG was founded in 2004 and has offices in Zurich, Switzerland, and Concord, Massachusetts, USA [6] - The company is pioneering the design and development of DARPin therapeutics, with a primary focus on oncology, and collaborates with leading pharmaceutical companies to enhance its proprietary programs [6]